| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | 0.17 | 0.3 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.18 | 0.3 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.3 |